RhumbLine Advisers’s MaxCyte MXCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $328K | Sell |
150,460
-2,574
| -2% | -$5.61K | ﹤0.01% | 2931 |
|
|
2025
Q1 | $418K | Sell |
153,034
-621
| -0.4% | -$1.7K | ﹤0.01% | 2684 |
|
|
2024
Q4 | $639K | Buy |
153,655
+2,402
| +2% | +$9.99K | ﹤0.01% | 2508 |
|
|
2024
Q3 | $588K | Sell |
151,253
-6,363
| -4% | -$24.8K | ﹤0.01% | 2593 |
|
|
2024
Q2 | $618K | Buy |
157,616
+20,864
| +15% | +$81.8K | ﹤0.01% | 2521 |
|
|
2024
Q1 | $573K | Buy |
136,752
+3,901
| +3% | +$16.3K | ﹤0.01% | 2579 |
|
|
2023
Q4 | $624K | Buy |
132,851
+1,443
| +1% | +$6.78K | ﹤0.01% | 2537 |
|
|
2023
Q3 | $410K | Sell |
131,408
-91
| -0.1% | -$284 | ﹤0.01% | 2729 |
|
|
2023
Q2 | $604K | Sell |
131,499
-3,644
| -3% | -$16.7K | ﹤0.01% | 2574 |
|
|
2023
Q1 | $669K | Buy |
135,143
+7,072
| +6% | +$35K | ﹤0.01% | 2304 |
|
|
2022
Q4 | $699K | Buy |
128,071
+1,484
| +1% | +$8.1K | ﹤0.01% | 2307 |
|
|
2022
Q3 | $823K | Buy |
126,587
+7,403
| +6% | +$48.1K | ﹤0.01% | 2250 |
|
|
2022
Q2 | $564K | Buy |
119,184
+14,306
| +14% | +$67.7K | ﹤0.01% | 2436 |
|
|
2022
Q1 | $733K | Buy |
104,878
+11,184
| +12% | +$78.2K | ﹤0.01% | 2260 |
|
|
2021
Q4 | $955K | Buy |
93,694
+82,957
| +773% | +$846K | ﹤0.01% | 2234 |
|
|
2021
Q3 | $131K | Buy |
+10,737
| New | +$131K | ﹤0.01% | 2968 |
|